• LAST PRICE
    0.9300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.9200/ 5
  • Ask / Lots
    1.1000/ 1
  • Open / Previous Close
    --- / 0.9300
  • Day Range
    ---
  • 52 Week Range
    Low 0.9000
    High 3.0000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.9
TimeVolumeCNVI
09:32 ET50000.95
10:24 ET10000.94
10:26 ET5000.95
10:29 ET5000.95
01:29 ET10000.95
01:51 ET5000.94
02:39 ET35000.94
03:10 ET5000.93
04:00 ET20000.93
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaCNVI
Conavi Medical Corp
41.2M
-15.0x
---
CanadaNSCI
Nanalysis Scientific Corp
41.3M
-2.9x
---
CanadaKOVO
Kovo+Holdings Inc
8.0M
-0.5x
---
CanadaNURS
Hydreight Technologies Inc
18.5M
-10.5x
---
CanadaPINK
Perimeter Medical Imaging AI Inc
40.6M
-1.8x
---
CanadaTLT
Theralase Technologies Inc
60.2M
-13.9x
---
As of 2024-11-13

Company Information

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.

Contact Information

Headquarters
76 Berkeley StreetTORONTO, ON, Canada M5A 2W7
Phone
416-548-7522
Fax
416-548-7522

Executives

Chief Executive Officer, Director
Thomas Looby
Chief Financial Officer
Stefano Picone
Director
Susan Allen
Director
Aaron Davidson
Director
Robert Mitchell

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$41.2M
Revenue (TTM)
$1.3M
Shares Outstanding
44.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.79
EPS
$-0.06
Book Value
$0.06
P/E Ratio
-15.0x
Price/Sales (TTM)
31.1
Price/Cash Flow (TTM)
---
Operating Margin
-604.84%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.